News

GHS patients paying €20-plus drug co-payments for fifth month with no quick fix in sight

In-Cyprus · 2026-06-10

AI SUMMARY

• What happened: Approximately 10,000 patients in Cyprus, primarily elderly, have been paying over €20 in drug co-payments for five consecutive months due to unresolved pricing issues in the General Health System (GHS). • Why it matters: The situation poses a significant risk to patients who lack alternative medication options, with calls for urgent intervention from health authorities to address the financial burden and ensure access to necessary treatments. • What to watch next: Ongoing negotiations between the Health Insurance Organisation (HIO) and pharmaceutical companies regarding co-payment adjustments for affected drugs, as well as potential government actions to reform the current drug pricing system.

Local drugsghshealthhioosakpatientsTop News GHS patients paying €20-plus drug co-payments for fifth month with no quick fix in sight Ghs Patients Paying €20 Plus Drug Co Payments For Fifth Month With No Quick Fix In Sight Relevant News GHS patients paying €20-plus drug co-payments for fifth month with no quick fix in sight 10 June 2026 Cabinet throws farmers a lifeline with 3.5 million cubic metres of extra irrigation water 10 June 2026 Things to do on Wednesday, June 10 10 June 2026 Marilena Panayi 10 June 2026 FacebookXWhatsAppEmailPrintViber Around 10,000 patients — most of them elderly — have been paying more than €20 a month in drug co-payments through the General Health System (GHS) for five consecutive months, and a deal reached between the Health Insurance Organisation (HIO) and pharmaceutical companies offers them no immediate relief. Marios Kouloumas, honorary president of the Cyprus Federation of Patient Associations (OSAK), told Phileleftheros the situation was urgent. “This is a problem whose solution should have been found yesterday, because we are talking about around 10,000 patients, the majority of them elderly, whom we are putting at risk since they essentially have no alternative drug option,” he said. Three cases have been logged with OSAK’s Patient Observatory. One patient living on public assistance said the benefit was not enough to cover the high co-payment and that the drug in question was his only safe treatment option. A second elderly patient filed a separate complaint. A third contacted the HIO a month ago asking whether the co-payment would be reduced and has yet to receive a reply. How the problem started The problem began after a drug price revision in February, Kouloumas said. When the patent on one drug in a particular category expired, it affected the pricing of the other products in the same group. The drugs belong to what is known as the “me too” category — medicines that treat the same condition but contain different active substances, meaning many patients cannot simply switch to another product. “This situation is unacceptable,” Kouloumas said. Failed negotiations OSAK raised the alarm from the first month. A meeting was subsequently held at the HIO with pharmaceutical companies present, at which a cap on co-payments for the affected drug category was discussed. OSAK’s position was that patients should pay no co-payment at all when no alternative drug exists and their own medication has not changed in price. The HIO largely accepted the cap proposal, but the pharmaceutical companies rejected it and submitted a counter-proposal of their own — one the HIO in turn rejected because it would have required a revision of the entire co-payment calculation system. A further meeting was held under the Health Minister but again produced no agreement. HIO and the companies have now reached a deal, Kouloumas said, under which whenever a similar problem arises the HIO will negotiate with the affected company to agree a new co-payment. For the specific cardiac drug at the centre of the current crisis, however, those negotiations have not yet begun. “Nobody knows when they will conclude or where the co-payment will be set,” he said. Call for action “It is inconceivable that we reach agreements and decisions that do not put the patient first,” Kouloumas said, calling on the Health Minister to intervene directly and deliver a solution that helps citizens. He said options beyond a co-payment cap exist, including reconsidering the “me too” drug category itself. “Drugs that contain different active substances must be treated as different drugs,” he said. If no meaningful decisions are taken now, he warned, patients will continue to bear the cost every time a drug price list is revised or a patent expires. Read more: Pharmacists warn EU prescription scheme could leave Cypriot patients short of medicines Subscribe to our Newsletter Latest News Cabinet throws farmers a lifeline with 3.5 million cubic metres of extra irrigation water Things to do on Wednesday, June 10 Mainly sunny with afternoon storms in the mountains through the weekend Iran hits Fifth Fleet in Bahrain as US restarts attacks Cyprus must do more for isolated elderly, welfare body says after woman found dead in flat Freedom of expression cannot become cover for defamation and misinformation, says Costas Cleanthous Young man found with stab wounds in Limassol taken to hospital Follow en.philenews on Google News and be the first to know all the news about Cyprus and the world.

Source: In-Cyprus
RELATED NEWS

More Stories

All News
News

Eurobank launches share buyback programme worth €288 million

• What happened: Eurobank S.A. has launched a €288 million share buyback programme, approved by shareholders and the European Central Bank, allowing the bank to...

News

AEL secures environmental approval for new sports centre

• What happened: AEL football club received environmental approval for a new sports centre in Kolossi, which will include two football fields and a three-level ...

News

Four arrested in criminal organisation probe

• What happened: Four individuals, including two businessmen from Larnaca and Nicosia, were arrested in a police operation investigating organised crime activit...

News

Charalambides says Alma fell short of expectations

• What happened: Alma MP Irene Charalambides expressed disappointment over her party's parliamentary election result of 5.8%, which fell short of her expec...

News

Larnaca and Nicosia businessmen arrested in organised crime operation spanning three years

• What happened: Four individuals, including businessmen from Larnaca and Nicosia, were arrested in a police operation for suspected involvement in organized cr...

News

Household or business: which eurozone countries offer the best deposit rates?

• What happened: Cyprus ranks among the lowest in the eurozone for deposit interest rates, with household rates at 1.20% and business rates at 1.23%, significan...